Advertisement
The third quarter results will be announced on October 30th, prior to theconference call.
To participate in the conference call, dial 866-575-6538 (and confirmationcode # 6490210) approximately 5 to 10 minutes prior to the scheduled starttime. If you are unable to participate, a digital replay of the call will beavailable from Thursday, October 30, from 7:30 p.m. ET until midnight onThursday, November 13, by dialing 888-203-1112 and using confirmation code #6490210.
Advertisement
The live broadcast of PhotoMedex, Inc.'s quarterly conference call will beavailable online by going to www.photomedex.com and clicking on the link toInvestor Relations, and at www.streetevents.com. The online replay will beavailable shortly after the call at those sites.
About PhotoMedex
PhotoMedex offers a wide range of products and services across multiplespecialty areas, including dermatology, urology, gynecology, orthopedics andother surgical specialties. PhotoMedex is a leader in the development,manufacturing and marketing of medical laser products and services. PhotoMedexalso develops and markets products based on its patented, clinically provenCopper Peptide technology for skin health, hair care and wound care.PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons,spas and salons and through licenses with strategic partners into the consumermarket, including a long-term worldwide license agreement with Neutrogena(R),a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R),VitalCopper(R), Simple Solutions(R) and AquaSante(R).
Some portions of the conference call, particularly those describingPhotoMedex' strategies, operating expense reductions and business plans, willcontain forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. While PhotoMedex is working to achieve those goals,actual results could differ materially from those projected in theforward-looking statements as a result of a number of factors, includingdifficulties in marketing its products and services, need for capital,competition from other companies and other factors, any of which could have anadverse effect on the business plans of PhotoMedex, its reputation in theindustry or its results. In light of significant uncertainties inherent inforward-looking statements included herein and in the conference call, theinclusion of such information in the conference call should not be regarded asa representation by PhotoMedex or its subsidiaries that the forward lookingstatements will be achieved.Company Contact: Investor Contacts: PhotoMedex, Inc. Lippert/Heilshorn & Associates, Inc. Dennis McGrath, CFO Kim Sutton Golodetz ([email protected]) 215-619-3287 212-838-3777 [email protected] Bruce Voss ([email protected]) 310-691-7100
SOURCE PhotoMedex, Inc.
